Phase 1/II Clinical Study of SYS6043 in the Treatment of Advanced/Metastatic Solid Tumors

Clinical trial NCT07415863 · RECRUITING

Trial details

NCT number: NCT07415863
Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced/Metastatic Solid Tumors

Start date: 2024-12-30
Primary completion: 2027-12-30
Enrollment: 820

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.